Jacobi Capital Management’s Novavax NVAX Stock Holding History

Jacobi Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-567	Closed	-$118K	–	1011
2021 Q3	$118K	Buy	567 +307	+118%	+$67.7K	0.02%	493
2021 Q2	$55K	Hold	260	–	–	0.01%	602
2021 Q1	$47K	Buy	+260	New	+$51.8K	0.01%	589
2020 Q4	–	Sell	-200	Closed	-$22K	–	1346
2020 Q3	$22K	Sell	200 -800	-80%	-$97.5K	﹤0.01%	651
2020 Q2	$83K	Buy	+1,000	New	+$38.2K	0.02%	388

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jacobi Capital Management's NVAX Position: Q4 2021 in Review

Jacobi Capital Management sold out of Novavax (NVAX) in Q4 2021, closing a stake of 567 shares — an estimated $118K sold.

Jacobi Capital Management first reported a position in NVAX in Q2 2020 and held it in 5 quarters. The position peaked at $118K in Q3 2021. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

Jacobi Capital Management reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 567 Novavax shares in Q4 2021, an estimated $118K.
Jacobi Capital Management first reported a position in Novavax in Q2 2020 and held it in 5 quarters.
Jacobi Capital Management's Novavax position peaked at $118K in Q3 2021.
429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.